5 burning questions about FDA's 'aggressive' deployment of AI for scientific review
FDA's plan to rapidly deploy a generative AI tool to assist with its scientific review process raises questions about transparency and risks .
Read the original at STAT News ↗
- Topics
- HealthcareChatbots & LLMs
- Mentions
- FDA
- Tracked via
- “AI Risks”